Track insider transactions across markets
| 30 days | 90 days | 120 days | |
|---|---|---|---|
| Average return | -10% | 8.2% | 15.1% |
| Success rate | 0% | 68% | 82% |
| Transactions |
7
100% Buy
|
34
71% Buy
|
47
69% Buy
|
| Position | Company | Period |
|---|---|---|
| Chief Medical Officer | electroCore, Inc. | March 8, 2019 - |
| Director | Immune Pharmaceuticals Inc | March 6, 2019 - |
| President, Interim Chief Executive Officer, Chief Operating Officer, Chief Medical Officer, Director | Immune Pharmaceuticals Inc | Aug. 28, 2018 - March 6, 2019 |
| Chief Operating Officer, Chief Medical Officer | Immune Pharmaceuticals Inc | Aug. 14, 2017 - Aug. 28, 2018 |
| Independent Director | Navidea Biopharmaceuticals Inc | March 23, 2016 - Oct. 9, 2017 |
| Chief Executive Officer | Brainstorm Cell Therapeutics Inc | June 9, 2014 - Sept. 22, 2015 |
Search